The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MicroRNA-based signatures of early and late immune-related adverse events to anti-PD1 treatment.
 
Joanne Weidhaas
Stock and Other Ownership Interests - Mira Dx; Mira Dx (I)
Patents, Royalties, Other Intellectual Property - I have patents filed by Yale University that have been licensed to MiraDx. There are royalty sharing agreements.
 
Kristen McGreevy
Employment - Mira Dx
 
Alexandra Drakaki
Employment - ATHOS THERAPEUTICS (I); ATTICA SCIENCES (I); Dyania Health (I)
Leadership - ATHOS THERAPEUTICS (I); ATTICA SCIENCES (I)
Stock and Other Ownership Interests - Alimera Sciences (I); Athos Therapeutics (I); ATTICA SCIENCES; Dyania Health (I); Kyn therapeutics (I); Moderna Therapeutics (I); PROTEAS BIOANALYTICS (I); Urogen pharma (I)
Consulting or Advisory Role - AstraZeneca; AVEO; Bristol-Myers Squibb; Daichi-Sanchyo; DYANIA HEALTH; EMD Serono; EMD Serono; Exelixis; Infinity Pharmaceuticals; Janssen; Loxo/Lilly; Merck; PACT Pharma; RADMETRIX; Roche/Genentech; Seagen
Research Funding - AstraZeneca (Inst); BMS (Inst); Genentech/Roche (Inst); Immunomedics/Gilead (Inst); Infinity Pharmaceuticals (Inst); Jounce Therapeutics (Inst); Kite/Gilead; Merck Sharp & Dohme (Inst); Pfizer (Inst); Seattle Genetics/Astellas (Inst)
Patents, Royalties, Other Intellectual Property - My significant other has several patents with UCLA, Harvard Medical School, Athos Therapeutics, Proteas Bioanalytics and ATTICA Sciences (I)
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Seagen
 
Susan McCloskey
No Relationships to Disclose
 
Kelly McCann
Honoraria - OncLive/MJH Life Sciences; PER
Consulting or Advisory Role - Lilly; Puma Biotechnology; Tersera
Speakers' Bureau - Lilly
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); H3 Biomedicine (Inst); Immunomedics (Inst); Lilly (Inst); Merck (Inst); Olema Oncology (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Lilly
 
Rena Callahan
Honoraria - Curio Science; IDEOlogy Health; MJH Life Sciences
Consulting or Advisory Role - Arvinas; AstraZeneca/Daiichi Sankyo; Gilead Sciences; Lilly; Novartis; Pfizer; Roche/Genentech; Stemline Therapeutics
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; Gilead Sciences; Hologic/Biotheranostics; Lilly; Novartis; Stemline Therapeutics
Research Funding - Celcuity (Inst); Lilly (Inst); Roche/Genentech (Inst)
 
John Glaspy
No Relationships to Disclose
 
Donatello Telesca
No Relationships to Disclose